Cargando…

Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome

Neuroendocrine tumors are tumors that arise from the enterochromaffin cells in the neuroendocrine tissue found throughout the body, particularly the digestive tract, pancreas, and thymus. Neuroendocrine tumors of the esophagus are extremely rare and highly aggressive in nature. We present the case o...

Descripción completa

Detalles Bibliográficos
Autores principales: Umar, Zaryab, Ilyas, Usman, Otusile, Ibironke, Landry, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060759/
https://www.ncbi.nlm.nih.gov/pubmed/35509743
http://dx.doi.org/10.7759/cureus.23720
_version_ 1784698575128625152
author Umar, Zaryab
Ilyas, Usman
Otusile, Ibironke
Landry, Ian
author_facet Umar, Zaryab
Ilyas, Usman
Otusile, Ibironke
Landry, Ian
author_sort Umar, Zaryab
collection PubMed
description Neuroendocrine tumors are tumors that arise from the enterochromaffin cells in the neuroendocrine tissue found throughout the body, particularly the digestive tract, pancreas, and thymus. Neuroendocrine tumors of the esophagus are extremely rare and highly aggressive in nature. We present the case of a 55-year-old Hispanic male who initially presented to the emergency department with right-sided abdominal pain. Imaging revealed innumerable lesions occupying half of the liver parenchyma. Subsequent endoscopy with biopsy of the esophageal and liver lesions along with immunohistochemistry staining was suggestive of a large cell neuroendocrine tumor. He later presented with generalized weakness and right-sided abdominal pain with worsening hepatic and renal function. Over the course of the patient's stay in the hospital, his mental status progressively deteriorated. Given the deranged hepatic and renal function, chemotherapy could not be initiated. The patient's family decided against hemodialysis considering his poor prognosis and the patient expired on day 15 of admission. The case report highlights the aggressiveness of one of the rare esophageal malignancies. It is crucial to establish diagnosis at the earlier stages of the disease with prompt treatment in order to avoid serious complications such as hepatorenal syndrome, which resulted in rapid deterioration of our patient's clinical status. More research is necessary in order to establish guidelines to treat neuroendocrine tumors of the esophagus.
format Online
Article
Text
id pubmed-9060759
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-90607592022-05-03 Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome Umar, Zaryab Ilyas, Usman Otusile, Ibironke Landry, Ian Cureus Gastroenterology Neuroendocrine tumors are tumors that arise from the enterochromaffin cells in the neuroendocrine tissue found throughout the body, particularly the digestive tract, pancreas, and thymus. Neuroendocrine tumors of the esophagus are extremely rare and highly aggressive in nature. We present the case of a 55-year-old Hispanic male who initially presented to the emergency department with right-sided abdominal pain. Imaging revealed innumerable lesions occupying half of the liver parenchyma. Subsequent endoscopy with biopsy of the esophageal and liver lesions along with immunohistochemistry staining was suggestive of a large cell neuroendocrine tumor. He later presented with generalized weakness and right-sided abdominal pain with worsening hepatic and renal function. Over the course of the patient's stay in the hospital, his mental status progressively deteriorated. Given the deranged hepatic and renal function, chemotherapy could not be initiated. The patient's family decided against hemodialysis considering his poor prognosis and the patient expired on day 15 of admission. The case report highlights the aggressiveness of one of the rare esophageal malignancies. It is crucial to establish diagnosis at the earlier stages of the disease with prompt treatment in order to avoid serious complications such as hepatorenal syndrome, which resulted in rapid deterioration of our patient's clinical status. More research is necessary in order to establish guidelines to treat neuroendocrine tumors of the esophagus. Cureus 2022-04-01 /pmc/articles/PMC9060759/ /pubmed/35509743 http://dx.doi.org/10.7759/cureus.23720 Text en Copyright © 2022, Umar et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Gastroenterology
Umar, Zaryab
Ilyas, Usman
Otusile, Ibironke
Landry, Ian
Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
title Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
title_full Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
title_fullStr Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
title_full_unstemmed Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
title_short Large-Cell Esophageal Neuroendocrine Tumor Leading to Hepatorenal Syndrome
title_sort large-cell esophageal neuroendocrine tumor leading to hepatorenal syndrome
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060759/
https://www.ncbi.nlm.nih.gov/pubmed/35509743
http://dx.doi.org/10.7759/cureus.23720
work_keys_str_mv AT umarzaryab largecellesophagealneuroendocrinetumorleadingtohepatorenalsyndrome
AT ilyasusman largecellesophagealneuroendocrinetumorleadingtohepatorenalsyndrome
AT otusileibironke largecellesophagealneuroendocrinetumorleadingtohepatorenalsyndrome
AT landryian largecellesophagealneuroendocrinetumorleadingtohepatorenalsyndrome